1241 ET - Hims & Hers Health's Zava acquisition will expand the company's footprint to major European countries with categories that overlap nicely with its existing offerings, BofA Securities analysts said in a note. However, expanding internationally is a risky move as Hims' core U.S. growth slows. The strategy could reflect product saturation and rising competition domestically. U.S. healthcare technology companies, like Oracle's Cerner and Teladoc's BetterHelp, have had little success in such markets given different regulatory environments in each country. Questions around Hims' future growth prospects remain, the analysts said.(kelly.cloonan@wsj.com)

(END) Dow Jones Newswires

June 03, 2025 12:41 ET (16:41 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.